Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
This study is a Phase 4, open-label, single group study in which at least 55 evaluable adult
male patients undergoing miltefosine treatment for mucocutaneous leishmaniasis will provide
semen samples for spermiogram analysis of sperm parameters.